Volpara receives regulatory clearance in Japan and Taiwan

 20-Nov-17, Sys-con 

Volpara Solutions announced it has received regulatory clearances for its suite of quantitative breast imaging tools in Japan and Taiwan, as a Class II medical device. 

Image: Volpara Solutions

Japan has approximately 65 million women and some 5 million are screened for breast cancer using mammography each year. It is estimated that Japan has 3,200 mammography machines, making it one of the world's largest users of mammography outside the US. The incidence of breast cancer is rapidly increasing. For this reason, breast cancer screening and increasing compliance are areas of focus for the government. 

 Read the full article 

 Healthcare insights